Table 1. Cancer patients included in the survival analysis in Kampala, Uganda, 1993–1997.
| Cancer site | No.a | Patients with complete data | Patients lost to follow-up (%) | Histologically verified (%) |
|---|---|---|---|---|
| Nasopharynx | 50 | 31 | 19 (30.2) | 78.0 |
| Oesophagus | 182 | 151 | 31 (15.8) | 39.6 |
| Stomach | 91 | 67 | 24 (23.1) | 48.4 |
| Colorectal | 104 | 81 | 23 (20.0) | 60.6 |
| Liver | 117 | 101 | 16 (12.0) | 33.3 |
| Lung | 50 | 41 | 9 (16.4) | 62.0 |
| Breast | 174 | 96 | 78 (33.5) | 63.2 |
| Cervix uteri | 285 | 149 | 136 (29.6) | 63.9 |
| Ovary | 69 | 48 | 21 (28.0) | 52.2 |
| Prostate | 161 | 119 | 42 (19.7) | 72.7 |
| Eye | 88 | 39 | 49 (35.0) | 72.7 |
| Thyroid | 41 | 20 | 21 (41.2) | 80.5 |
| Lymphomas | 199 | 117 | 82 (32.7) | 79.4 |
| Kaposi sarcoma | 220 | 145 | 75 (30.1) | 83.2 |
| Total | 1831 | 1205 | 626 (26.8) | 61.8 |
a
Excluding patients with missing/invalid data or no follow-up after diagnosis.